We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
-14.14%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$208M
AUM Growth
-$40M
Cap. Flow
-$3.57M
Cap. Flow %
-1.71%
Top 10 Hldgs %
30.92%
Holding
571
New
36
Increased
83
Reduced
101
Closed
72

Top Sells

Rank Stock Value
1
ANDV
Andeavor
ANDV
+$5.51M
2
SWKS icon
Skyworks Solutions
SWKS
+$2.89M
3
GD icon
General Dynamics
GD
+$1.66M
4
LRN icon
Stride
LRN
+$1.26M
5
BEAT
BioTelemetry, Inc.
BEAT
+$1.08M

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.22%
2 Technology 11.59%
3 Financials 9.66%
4 Healthcare 9.21%
5 Consumer Discretionary 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
251
Tvardi Therapeutics
TVRD
$23.5M
$19K 0.01%
41
KSU
252
DELISTED
Kansas City Southern
KSU
$19K 0.01%
200
ACWX icon
253
iShares MSCI ACWI ex US ETF
ACWX
$12.3B
$18K 0.01%
420
DFS
254
DELISTED
Discover Financial Services
DFS
$18K 0.01%
304
+1
+0.3% +$69
HTD
255
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$859M
$18K 0.01%
900
IBDR icon
256
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.25B
$18K 0.01%
800
USRT icon
257
iShares Core US REIT ETF
USRT
$4.38B
$18K 0.01%
400
VO icon
258
Vanguard Morningstar Mid-Cap ETF
VO
$105B
$18K 0.01%
512
ELVT
259
DELISTED
Elevate Credit, Inc.
ELVT
$18K 0.01%
4,054
BHC icon
260
Bausch Health
BHC
$2.12B
$17K 0.01%
918
+24
+3% +$571
EMLP icon
261
First Trust North American Energy Infrastructure Fund
EMLP
$4.11B
$17K 0.01%
800
MRTX
262
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$17K 0.01%
400
COP icon
263
ConocoPhillips
COP
$170B
$16K 0.01%
250
FLS icon
264
Flowserve
FLS
$9.03B
$16K 0.01%
426
HBAN icon
265
Huntington Bancshares
HBAN
$33.8B
$16K 0.01%
1,349
ICLR icon
266
Icon
ICLR
$13.3B
$16K 0.01%
120
IGE icon
267
iShares North American Natural Resources ETF
IGE
$802M
$16K 0.01%
600
NTES icon
268
NetEase
NTES
$76.5B
$16K 0.01%
350
REGN icon
269
Regeneron Pharmaceuticals
REGN
$79.7B
$16K 0.01%
43
RTX icon
270
RTX Corp
RTX
$263B
$16K 0.01%
238
STE icon
271
Steris
STE
$20.5B
$16K 0.01%
150
AABA
272
DELISTED
Altaba Inc
AABA
$16K 0.01%
269
DAL icon
273
Delta Air Lines
DAL
$51.9B
$15K 0.01%
301
REM icon
274
iShares Mortgage Real Estate ETF
REM
$492M
$15K 0.01%
375
SIR
275
DELISTED
SELECT INCOME REIT
SIR
$15K 0.01%
2,050
-3,524
-63% -$29.6K

Similar funds

AlphaMark Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, AlphaMark Advisors held 571 positions worth $208M, down 16% from $248M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

AlphaMark Advisors's Q4 2018 filing shows 36 new, 83 increased, 101 reduced and 72 closed positions. Its largest new stake was iShares MSCI Emerging Markets Small-Cap ETF: 71,200 shares worth $2.98M. The largest sale was Andeavor, an estimated $5.51M.

By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

  • AlphaMark Advisors's largest Q4 2018 buy was iShares MSCI Emerging Markets Small-Cap ETF: 71,200 shares worth $2.98M.
  • AlphaMark Advisors added most to iShares Russell 2000 ETF in Q4 2018, an estimated $4.88M increase.
  • AlphaMark Advisors's biggest Q4 2018 reduction was Skyworks Solutions, cutting an estimated $2.89M.
  • AlphaMark Advisors fully exited Andeavor in Q4 2018, selling an estimated $5.51M.
  • AlphaMark Advisors's ten largest holdings make up 31% of its $208M portfolio in Q4 2018.
  • AlphaMark Advisors opened 36 new positions and closed 72 in Q4 2018.
  • AlphaMark Advisors's portfolio value fell 16% quarter-over-quarter to $208M.

Based on AlphaMark Advisors's 13F filing for Q4 2018, filed 6 Feb 2019.